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INTRODUCTION
The undesirable environmental effects of lead have been
recognized for many years in industrial workers, people or
animals coming into contact with the effluence from factories,
and in people or animals exposed to lead-containing products,
such as paint. This widespread pollution has resulted in
efforts by environmentalists and health orientated professions
to minimize lead exposure to humans and populations of
animals thought to be at risk.
Sub-clinical lead poisoning is common in humans as well
as animals. Because of possible mental retardation in
children, subclinical poisoning is gaining world-wide concern.
Lead also affects the central nervous, renal, hepatic,
hemopoietic and gastrointestinal systems. It is thought
to cause anemia by interferring with enzymes concerned with
heme synthesis and by shortening the life span of circulating
erythrocytes. Other clinical signs of lead are evidence of
abdominal pain, vomiting, constipation, convulsions, emaciation
and muscular weakness. Diagnosis is a clinical concern and
the establishment of early diagnostic criteria is an important
goal of clinical scientists.
The purpose of this study is to evaluate the effect of
chronic lead exposure in dogs on the hemopoietic system and
to study the possible correlation between blood lead levels
and hematologic, biochemical and bone marrow parameters.
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SUMMARY
The effect of chronic oral lead acetate administration
on the canine bone marrow was studied. Two dogs served as
control, 4 received 2 mg lead/kg daily and 4 received 5 mg
lead/kg daily. Lead dosing was conducted for 13 weeks, after
which one-half of each group was treated with calcium ethylene
diaminetetracetic acid (CaEDTA) . All animals were then observed
for another 4 weeks. Blood lead values and bone marrow cytology
were monitored weekly during the 18 weeks of study. The lead
dosed dogs had a lower rate of weight gain than the control
dogs. Clinical signs of toxicosis were observed after 6 weeks
in one dog in the high lead group. Anorexia, body weight loss,
depression, muscular weakness and trembling were seen. The
signs were reversed with CaEDTA treatment. Blood lead levels
increased in all lead dosed dogs. Lead caused increases in bone
marrow segmented neutrophils and myeloid series cells and
increased myeloid zerythroid ratios. Blood lead levels and M:E
ratios decreased after cessation of lead administration.
Lead is used in the manufacture of storage batteries,
accounting for approximately one-third of the total industrial
lead consumption. However, the use of lead as antiknock in
fuel additives, the second most prevalent use, is a major
source of pollution. The concentration of atmospheric lead
3has been estimated at 0.0005 ug/M as compared to an average
3 1
of 0.79 ug/M in urban air. The amount of lead in fresh
2
air has been estimated at 1 to 10 ug/L. Campbell et al
has shown that at least three of the enzymes involved in heme
biosynthesis are inhibited by lead and may be the cause of
lead induced anemia. Goldberg has stated that anemia from
lead poisoning is a result of a disorder in heme synthesis.
The purpose of this study was to evaluate the effects of
chronic lead exposure on the hemopoietic system of dogs and to
document the correlation between blood lead levels and bone
marrow cytologic parameters.
Materials and Methods
Ten male beagle dogs, 10 weeks of age, were purchased
from Theracon, Inc., Topeka, Kansas. Routine anthelmintic
control and vaccination were practised. The dogs were fed
dry dog food between 1200 to 2400 hours and offered water
ad libitum in individual cages. The dogs were allowed two
weeks acclimatization prior to exposure to lead.
They were divided randomly into three groups. Two con-
trol dogs (group 1) were given empty gelatin capsules daily.
Four dogs (group 2) received 2 mg of lead (as the acetate) /kg
in gelatin capsules daily between 0800-0900 hours. Four dogs
(group 3) received 5 mg of lead (as the acetate) /kg orally on
the same time schedule. Bone marrow biopsies were taken from
each dog before the study was initiated; subsequent biopsies
were taken every week from alternately one-half the dogs of
every group. Blood was taken from each animal before the
study and then every week between 0800-0900 hours. The study
lasted for 18 weeks with the lead dosed groups receiving lead
the first 13 weeks. After that one-half the dogs from each
group were treated with calcium ethylene diaminetetraacetic
acid (CaEDTA).^" Any animal observed sick from the lead expo-
sure was treated immediately with CaEDTA and removed from lead
dosing. CaEDTA was given at the rate of 4.5 mg/kg of body
weight daily for 5 days. The daily dose was divided into four
equal portions and administered subcutaneously after dilution
with 5% dextrose solution to a concentration of about 10 mg
CaEDTA/ml
.
Sample collections .
Blood — 10-15 ml of blood was taken from the jugular vein
of each dog during stabilization and thereafter every week
during the 18 weeks of study. Samples were taken between 0800-
0900 hours on the same day of bone marrow biopsy. Heparin was
used as anticoagulant. The vials were capped immediately and
stored in a refrigerator pending blood lead determination.
Blood lead was determined by atomic absorption spectrophotometry
using standard methods described in the analytical manual for
the Perkin-Elmer 306 instrument; a graphite furnace (HFG) 2200
with deuterium background correction was employed.
Bone marrow — Animals were lightly anesthetized with
intravenous thiamylal sodium9 at a dose of 0.44 ml of 4%
solution/kg body weight. Bone marrow samples were collected
alternately from the right and left ileal crests of each dog
4 5 6'
as described by Coles , Perman et al , Penny et al , and Schalm.
Aseptic technique was observed throughout the surgical procedure
using a bone marrow biopsy needle 2.5 cm long by 16 g. Smears
were made immediately on marked slides. Wrights/Leishman stain
g
was used for staining as outlined by Coles.
Slides were scanned under low power to assess cell type
and density and to determine numbers of megakaryocytes; 500
9
marrow cells were then differentiated under oil immersion.
The myeloid :erythroid (M:E) ratios were calculated by enumer-
ating all nucleated cells of the myeloid series as a ratio of
all nucleated cells of the erythroid series. The myeloid
series included myeloblasts, promyelocytes (progranulocytes)
,
myelocytes, meta, band and segmented forms of neutrophils,
eosinophils, and basophils; the erythroid series included
rubriblasts, prorubricytes , rubricytes and metarubricytes
.
Statistical analysis of data — The SAS 76 computer
statistical package was used for data analysis. Analysis
of variance was performed for the 13-week lead dosing period
and the 4 weeks post lead dosing. Significance among groups
or treatment was tested with Duncan's Multiple Range test
10
at a probability level of 0.05.
Results
Clinical observations . The control dogs (group 1) had
a steady increase in body weight throughout the study. These
animals remained bright and alert, had very good appetite and
were clinically normal.
Group 2 dogs (2 mg lead/kg daily) also had a steady
increase in mean body weight, but this was not as consistent
or great as in the control group (Fig 1) . Although they ate
well throughout the study, group 2 dogs were not as bright and
alert as the control group.
Group 3 dogs (5 mg lead/kg daily) had consistent mean
body weight gains, but at a lower rate than the control animals
(Fig 1) . One animal in this group showed depression and
anorexia after day 42. A tender abdomen, muscular weakness
of the hind limbs and loss of weight were also observed. This
animal was treated with CaEDTA and improved after one week.
Other dogs in this group were not as bright and alert as the
control animals.
No seizures were observed in any of the lead dosed groups.
Blood lead level . The control dogs 1 blood lead levels
remained constant during the period of study, but a statisti-
cally significant increase in blood lead was observed in both
lead dosed groups (Fig 2) . The lead dosed groups also had
blood levels significantly different from each other (P 0.05),
with the highest level in the dogs receiving the high lead
dose.
Bone marrow cytology . Control dogs did not have any
significant changes of bone marrow cytology. Changes in the
bone marrow cytology were observed in the lead dosed groups.
Segmented neutrophils increased in both lead dosed groups.
Myeloid series cells had a trend to increase in both lead
dosed groups (Fig 3) , but the degree of increase was not
statistically significant. The M:E ratios increased in both
lead dosed groups compared to the control group (Fig 4) ; there
was no difference between the two lead dosed groups.
Large binuclear cells of the erythroid series cells
(megaloblasts) were frequently seen in the marrow smears of
the lead dosed groups. There were many naked nuclei of meta-
rubricytes on marrow smears in these animals. One of the dogs
in the low lead dosed group developed a marked hypocellularity
of the bone marrow, and for two consecutive biopsies there were
very few immature forms of bone marrow cells. No basophilic
stippling was observed in the bone marrow smears of either lead
dosed group during the study period. Mononuclear bone marrow
cells and other cells of the erythroid and myeloid series had
no change during the period of study.
Effect of CaEDTA therapy . The clinical signs of toxicosis
produced by lead in one animal were reversed after one week of
therapy. There were no statistical differences in the weekly
blood lead levels of animals treated with CaEDTA and those not
so treated. Blood lead levels dropped in both instances with
cessation of lead administration (Fig 2) . Myeloid series cells
and segmented neutrophils remained statistically elevated in
CaEDTA treated animals; however this was not of practical
significance due to the small sample size.
Discussion
The loss of weight, anorexia, tender abdomen and muscle
weakness observed in one of the high lead dosed dogs was also
reported by other authors ' in canine lead intoxication.
The lesser degree of severity in this study may be due to the
low dose levels used in this study, and the fact that lead is
poorly absorbed from oral administration. Toxic levels of
lead cause anorexia, colic, and weight loss by astringent
action on the mucosa of gastrointestinal tract, leading to
gastroenteritis; hence subsequent malabsorption of nutrients
and gradual emaciation results. Beliles suggests that weak-
ness of extensor muscles, as well as the gastrointestinal
signs, may be related to peripheral neuropathy and not to a
direct effect of lead on the intestinal mucosa. Other reported
11-13
gastrointestinal signs (vomiting and constipation ) were
not observed in this study. The absence of convulsions and
tremors /J" ' may have been due to the low dose or limited
exposure. However, convulsions can be periodic and thus dif-
ficult to observe.
Treatment of the one ill dog with CaEDTA reversed the
clinical signs promptly. The antidote acts by chelating lead
circulating in the blood, making it available for renal excre-
tion and thereby decreasing the blood lead level. In our
10
study , CaEDTA did net appear to reduce blood lead levels after
continuous lead exposure was stopped. This was probably due
to redistribution of lead to blood from the heavily burdened
body tissues, such as bone. The fact that 3 days elapsed
between the last CaEDTA treatment and the subsequent blood
lead determination allowed for this redistribution and
equilibrium.
Blood lead concentrations are expected to increase with
14 15dosing level and duration ' as observed in this study.
14Zook and Carpenter described blood lead values of 60 ug or
more of lead/100 ml of blood (0.6 ppm) as virtually diagnostic
of lead poisoning in dogs. Blood lead values of 40-50 ug/100
ml (0.4-0.5 ppm) are reported no indicate lead poisoning if
14
associated with typical signs and hematologic findings.
Although blood lead levels in our study increased with inten-
sity of lead dosing, only one dog had clinical signs of
intoxication. Despite the presence of blood levels considerably
above the diagnostic level of 60 ug/100 ml blood in the high
lead dosed dogs for several weeks, the other 3 dogs in this
group did not exhibit any clinical signs of poisoning other
than reduced body weight gain. This suggests that blood lead
levels at or in excess of the suggested diagnostic limit are
not necessarily associated with the expected overt clinical
signs of poisoning.
The changes observed in the bene marrow of the lead dosed
dogs were increased numbers of segmented neutrophils and
myeloid series cells and elevated M:E ratios. Many
11
workers ' ' have shown that lead may affect the early pre-
cursors of the erythroid series. Morse et al suggests that
the effects of lead on erythropoiesis in mice are due to intra-
medullary death of intermediate normoblasts. Waldron pro-
poses that lead has a profound effect on red cell precursors
in the bone marrow, producing nonspecific morphologic changes.
Nearly fifty times as much lead is found in human bone
marrow as in peripheral blood; 1.4 mg lead occurs/100 gm fresh
marrow, as compared to only 0.15 mg lead/100 gm in liver and
0.10 mg lead/100 gm in kidney. A patient whose blood lead
varies between 70 and 130 ug/100 ml blood will have a bone
17 13
marrow concentration of 4.2 to 9.2 mg lead/100 gm ' .It
is therefore logical that the effects of lead should be
demonstrable in the bone marrow, where young cells are most
susceptible to injury.
Increased M:E ratios were observed after day 63 in both
lead dosed groups; elevated M:E ratios have not previously
been reported in dogs exposed to lead. Lead may have a direct
suppressing effect on the erythroid series, allowing the
myeloid series cells to dominate, or it may interfere with
maturation and release of segmented neutrophils from the bone
marrow into the circulation. A study of myeloid and segmented
neutrophil kinetics could investigate this concept further.
19Calhoun found that four anemic horses with lead poisoning
had MsE ratios falling below 0.5. The values reflected active
erythrogenosis or decreased myeloid production. He found that
the number of rubricytes and metarubricytes were increased.
12
The effect of lead on M:E ratios resembles the effect
of chloramphenicol on the hemopoietic system of the dog and
20 21
cat. Penny et al showed that chloramphenicol increased
the M:E ratios significantly in dogs and cats and produced
22
severe depression of the bone marrow. Watson also observed
an increased M:E ratio in a dog with chloramphenicol
intoxication. The increased M:E ratios in the lead dosed
groups in this study were not as high as those observed
with chloramphenicol. This suggests that lead does not exert
the same quantitative effects on bone marrow erythroid cells
as chloramphenicol does.
The M:E ratios in our study declined gradually after
cessation of lead administration, indicating that this effect
was lead related. However, a slightly increased M:E ratio
should not be considered diagnostic of lead poisoning unless
other parameters, such as blood lead levels, are also elevated,
The marked hypocellularity observed in one animal in the
16 17lead dosed group is difficult to explain. Most workers '
have found general erythroid hypoplasia with lead toxicity.
Individual animal variation must not be overlooked in this
instance, since only one animal was observed to have poor
capacity for bone marrow regeneration.
There was no basophilic stippling observed in the bone
17
marrow smears of the lead dosed dogs. Waldron suggests
that a diagnosis cf lead intoxication is not dependent upon
the findings of basophilic stippling in bone marrov; or
13
peripheral blocd smears. Thus, although basophilic stippling
is reported to be consistent with lead poisoning, its absence
should not rule out that possibility.
Binuclear forms of the erythroid series were observed in
our study. This is similar to early findings cited by Waldron
who described these cells as megaloblasts . Binuclear forms
may result from abnormalities in mitosis and could be caused
17by lead. There were many naked nuclei from the bone marrow
smears of the lead dosed dogs. These nuclei are extruded from
metarubricytes , and their increased number may have been due
7
to the effect of lead on maturation of these cells.
17
14
Fig 1 — Body weights (kg) during the 13-week dosing period
in groups of dogs receiving 0, 2 or 5 mg lead/kg body weight
daily.
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Fig 2 — Blood lead levels (ug/100 ml) during 13-week dosing
and 4-week post dosing periods from groups of dogs receiving
(group 1) , 2 (group 2) or 5 (group 3) mg lead/kg body weight
daily.
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Fig 3 — Myeloid series cells/500 bone marrow cells counted
during 13-week dosing and 4-week post dosing from groups of
dogs receiving (group 1) , 2 (group 2) or 5 (group 3) mg
lead/kg body weight daily.
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Fig 4 — Ratio of myeloid series cells to erythroid series
cells during 13-week dosing and 4-week post dosing periods
from groups of dogs receiving (group 1) , 2 (group 2) and
5 (group 3) mg lead/kg body weight daily.
21
Q
</)
U.
O
Q
S||30 sapag pioj^Ajg oj sioq sauag pioiaA^ jo oijea
22
Task dewormer, Shell Chemicals, San Ramon, CA.
Enduracell dhp (Norden DM), Norden, Lincoln, NE
.
cPurina Dog Food, Ralston Purina Comp, St. Louis, MO.
Lead acetate, Mallinckrodt , Inc., St. Louis, MO.
eHavidole, Haver-Lockhart Laboratories, Shawnee, KS.
Atomic Absorption Spectrophotometer (Ass) , Perkin-Elmer,
Norwalk, Conn.
^Surital, Parke-Davis, Detroit, Mich.
Biopsy needle, Lue-Lock Hub, McGraw Park, III.
1SAS 76 Computer, SAS Inst. Inc., Raleigh, N.C.
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EFFECT OF CHRONIC LEAD EXPOSURE ON THE HEMATOLOGY,
BLOOD GLUTATHIONE AND BONE MARROW
NON-HEME IRON OF DOGS
by
Eric S. Mitema, F. W. Oehme and L. Penumarthy
Abstract ; Ten clinically normal male beagle dogs were used
in the study. Two dogs served as control, 4 received 2 mg
lead/kg/daily and 4 received 5 mg lead/kg/daily. Lead was
administered for 13 weeks, after which one-half of each
experimental group was treated with calcium ethylene
diaminetetraacetate (CaEDTA) for 5 days. All animals were
then monitored for another 4 weeks. Blood lead levels,
hematology, blood glutathione concentration, and the number
of bone marrow cells with stainable iron granules were measured
weekly during the 18-week experimental period. Clinical signs
of poisoning were observed only in one dog in the high dose
group after 6 weeks. The signs included emaciation, anorexia,
muscular weakness, evidence of abdominal pain and depression.
These signs were reversed with cessation of lead dosing and
CaEDTA treatment. Blood lead levels and the number of marrow
cells with non-heme iron increased in both lead-dosed groups;
nucleated red blood cells increased only in high lead dosed
group. There was a trend for an increased packed cell volume
in all groups; however, the high lead dosed group did not
increase as fast. No significant changes were observed in blood
28
glutathione concentration and in other hematologic parameters,
There were no differences in the parameters studied between
the dogs treated with CaEDTA and those not so treated. Elood
lead levels and the number of nucleated red blood cells
decreased after cessation of lead administration and the num-
ber of marrow cells with iron also tended to decrease after
lead removal.
Key-words : Lead exposure - blood lead levels - hematology -
blood glutathione - iron granules - dogs.
Lead poisoning is a common syndrome in domestic dogs,
but is infrequently recognized due to the difficulty in
detecting early clinical signs (Zook and Carpenter 1974)
.
Zook (1974, 1972b) reported blood lead levels and hematologic
findings. He suggested that blood lead levels of 6 ug or
more of lead/100 ml whole blood was diagnostic of lead intoxi-
cation if the accompanying clinical signs and hematological
parameters are present. Hematological parameters reported
included elevated white blood cell count (WBC) due to a left
shift, neutrophilic leukocytosis, normal hematocrit, eosino-
penia, nucleated RBC in peripheral smears and basophilic
stippling. The clinical signs of tender abdomen, depression,
emaciation, anorexia and muscular weakness were also reported
by Beliles (1972), Buck et al. (1976), Stowe et al. (1973),
and Zook and Carpenter (1969) in cases of lead poisoning.
No relationship between blood glutathione concentration and
29
blood lead levels has been reported. Brady et al. (1978)
reported decreased glutathione concentration in fasted beagle
dogs. Deposition of stainable non-heme iron granules in the
bone marrow has been reported by Kaplan et al . (1954), Kerr
(1957), Beutler et al. (1958), Waldron (1966), Albahary (1972)
and Ritcher (1978) in cases of lead poisoning.
The present experiments were conducted to study the effects
of chronic lead exposure on the hematology, blood glutathione
concentration, and iron granules in bone marrow of dogs and
to evaluate the use of these parameters in the early diagnosis
of lead intoxication.
MATERIALS AND METHODS
Experimental Animals and Protocol
Ten male beagle dogs, 10 weeks of age, were purchased
from Theracon, Inc., Topeka, Kansas. Routine anthelmintic
administration and vaccination was practised. The dogs were
offered dry Purina dog food daily between 1200-2400 hours and
given water ad libitum in individual cages. The dogs were
allowed two weeks acclimatization prior to exposure to lead
in the form of acetate. Lead acetate was manufactured by
Mallinckrodt , Inc., St. Louis, Mo., U.S.A.
Dogs were divided randomly into three groups. Two control
dogs (group A) were given empty gelatin capsules daily. Four
animals (group B) received 2 mg lead/kg in gelatin capsules
daily between 0800-0900 hours. Four dogs (group C) received
5 mg lead/kg orally en the same time schedule.
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The study lasted 18 weeks with lead-dosed groups receiving
lead for the first 13 weeks. Any animal which became clini-
cally sick from lead exposure during the first 13 weeks was
removed from lead dosing and treated with CaEDTA (HAVIDCTE,
Haver-Lockhart Laboratories, Shawnee Mission, Kansas, U.S.A.)
for 5 days. After the 13 weeks of lead dosing, half of the
animals from each group were treated with CaEDTA. All animals
were then monitored for 4 weeks. Bone marrow samples were col-
lected on alternate weeks from one-half the dogs in every group
while blood was collected from each animal weekly.
Sample Collections and Analysis
Blood . Between 10-15 ml of blood was taken from the
jugular vein of each dog during the stabilization period and
thereafter every week for 18 weeks between 0800-0900 hours.
Sodium ethylene diamine tetraacetate (EDTA) (manufactured by
Sherwood Medical Industries, St. Louis, Mo., U.S.A.) was used
as anticoagulant for hematology samples and heparin (manufactured
by Richer Laboratories, Inc., Northridge, California, U.S.A.)
was used similarly for blood collected for lead and glutathione
determinations. The vials were capped immediately pending
hematologic evaluation and assays for lead and glutathione
concentration.
The hematologic parameters—hematocrit (PCV) , total
white blood cell count (WBC) , total red blood cell count (RBC)
,
hemoglobin concentration (Kb) and differential counts—were
determined by standard methods (Schalm et al. 1975)
.
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Blood lead values were determined as ug/100 ml of whole
blood by atomic absorption spectrophotometry (ASS) using
methods described in the analytical manual for the Perkin-
Elmer 306 instrument, and using a graphite furnace 2200 with
deuterium background correction (manufactured by Perkin-
Elmer, Norwalk, Conn., U.S.A.).
Blood glutathione was determined by the method of Beutler
et al. (1963) using a double-beam spectrophotometer (manu-
factured by Hitachi-Perkin-Elmer , Norwalk, Conn., U.S.A.).
Bone marrow collection and iron staining . Animals were
anesthetized with thiamylal sodium (SURITAL, manufactured by
Parke-Davis, Detroit, Mich., U.S.A.) at a dose of 1 ml of
4% solution per 2.3 kg body weight. Bone marrow samples were
collected alternately from the right and left ileal crests of
each dog as described by Coles (1967), Perman et al. (1974),
Penny et al. (1970) and Schalm (1975). Aseptic technique was
observed employing a 16 g 2.54 cm long bone marrow biopsy
needle (supplied by Lue-Lock Hub, McGraw Park, 111., U.S.A.).
Marrow smears were made immediately on marked slides and
were stained for Prussian blue reaction (PB) by application
of potassium ferrocyanide and hydrochloric acid as described
in the method of Beutler (1972) . Stained smears were examined
under oil immersion. A portion of the smear in which marrow
cells were definitely spaced was uniformly and systematically
examined for identification of iron containing cells
(sideroblasts) . Each iron-ccntaining cell was tallied and
the mean of each group was calculated and compared.
32
CaEDTA Treatment
CaEDTA was given at the rate of 111 mg/kg of body weight
for 5 days. The daily dose was divided into four equal parts
and administered subcutaneously after dilution with 5% dextrose
to a concentration of 10 mg CaEDTA/ml. All animals were then
monitored for 4 weeks.
Statistical Analysis
The SAS 76 computer statistical package (SAS Institute,
Inc., P.O. Box 10066, Raleigh, N.C. 27605, U.S.A.) was used
for data analysis. Analysis of variance was performed for
blood lead and glutathione concentration and for the hemato-
logic parameters during the 13-week lead dosing and 4-week
post-lead dosing periods. The significance among the groups
or effect of EDTA treatment was tested with Duncan's Multiple
Range Test as described by Snedecor and Cochran (1971) at a
probability level of 0.05. Mean weekly numbers of marrow
cells with iron granules from each group was tested by linear
regression (Snedecor and Cochran 1971) at a probability level
of 0.05.
RESULTS
Blood lead levels . The control dogs' blood lead levels
remained constant during the whole period of study. A sta-
tistically significant increase (P^O.Ol) in blood lead was
observed in both lead-dosed groups (Fig 1) compared to con-
trol animals. The lead-dosed groups had blood lead levels
significantly different from one another.
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Clinical observations . Control animals had a steady
increase in body weight throughout the study. These animals
remained bright and alert, and had good appetite. The lead-
dosed dogs gained steadily in mean body weight, but less than
control dogs.
One dog in the high lead dose (5 mg Pb/kg) became clini-
cally ill on day 42 and was treated with CaEDTA. Clinical
signs observed were abdominal pain, depression, emaciation and
muscular weakness of the hind limbs. Other animals in this
group did not show any of these signs of toxicosis.
Convulsions were not observed in any of the lead-dosed
dogs
.
Hematologic findings . The hematologic parameters (WBC,
RBC, Hb, and differential counts) were not different between
the groups. The PCV increased in all groups, but did not
increase as rapidly in high lead dosed group (Fig 2) . This
difference was not, however, statistically significant. There
was an increased number of nucleated red blood cells (NRBC) in
the high lead dosed group (Fig 3) . No clinical anemia or baso-
philic stippling was observed in both lead-dosed groups.
Blood glutathione levels . No significant differences were
observed in blood glutathione (mg/gm Hb) between groups
(P 0.05); however, there were considerable weekly mean varia-
tions within the groups (Fig 4)
.
Iron granules . There was a trend of an increasing number
of bone marrow cells with iron granules in both lead-dosed
groups after day 56 (Fig 5)
.
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Effect of CaEDTA . The clinical signs of toxicosis pro-
duced by 5 mg lead/kg in one animal were reversed one week
after CaEDTA therapy.
There were no significant differences in the parameters
studied of the dogs treated with CaEDTA and those not so
treated. Blood lead levels decreased with cessation of lead
administration in both cases. Hematology, blood glutathione
concentration, and the numbers of bone marrow cells with iron
granules did not show any effect due to CaEDTA.
DISCUSSION
The blood lead concentration increased with level and
duration of dosing. Although blood levels increased, there
were no clinical signs in all, but one of the lead-dosed animals
Lead causes anorexia, evidence of abdominal pain, and weight
loss by its astringent action on the gastrointestinal mucosa,
leading to poor absorption of nutrients and gradual loss of
weight. The vomiting and constipation reported by Buck et al.
(1976) , Stowe et al. (1973) and Zook (1974) were not observed.
The absence of the seizures (Buck et al. 1976) is difficult to
explain, but since the seizures are reported to be periodic,
they may have been sporadic and not observed. A higher body
lead burden may be required to produce nervous activity.
No clinical anemia was observed in this study, but anemia
has been reported (Stowe et al. 19 73) . Anemia has been
reported to be mild and hypochromic, with hemoglobin concentra-
tion rarely falling below 9 gm% (Waldrom 1966) . There were no
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basophilic stippled cells observed; although these have been
reported, they are by no means a constant accompaniment of
lead poisoning (Waldrom 1966) . The reported increased number
of NRBC was observed in our high lead-dosed group. Stowe
et al. (1973) reported a significant anemia in dogs fed a low
calcium-phosphate diet with dietary lead dosing. He also
reported a decreased hemoglobin concentration, decreased PCV,
and increased numbers of NRBC. The absence of anemia observed
here may have been due to the normal levels of calcium and
phosphate in the diet of the dogs used. In this study we
observed a trend of increasing PCV in all groups, but this was
not as rapid in the high lead dosed group.
The mechanism by which lead causes anemia is not well
understood. Lead is thought to increase fragility of erythro-
cytes (Waldron 1966). Berk et al. (1970) reported a shortened
mean red cell survival time and concluded that the hemolytic
effect of lead was a direct action on mature red blood cells.
The increased mechanical fragility and shortened life span may
be the cause of the hemolytic anemia.
Nearly 50 times as much lead is found in bone marrow as
peripheral blood (/ilbahany 1972) ; it is therefore logical
that the effects of lead should be demonstrable in the marrow
and on heme synthesis in that tissue. At least two enzymes
in heme synthesis may be affected by lead (Campbell et al.
1977) . Delta-aminolevulinic acid dehydratase (ALA-D) is one
of the most lead-sensitive enzymes. Ferrochelatase (heme
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synthetase) (Ortzonsek 1967) which catalyzes the incorporation
of iron into the porphyrin structure is also inhibited by lead.
Lead inhibits these enzymes by combining with their sulfhydryl
(-SH) groups (Waldron 1966; Albahany 1972). Defective hemo-
globin synthesis due to one or both of these inhibitions may
therefore cause the reported anemia.
Glutathione was not significantly changed during the 18-
week study; however, considerable mean weekly variations
occurred in all groups (Fig 3) . Although Brady et al. (1978)
showed a significant glutathione decrease occurred in fasted
beagle dogs, no previous work has been reported on variations
in blood levels of glutathione in response to lead. Glutathione
is a tripeptide of three amino acids (glycine, glutamic acid,
and cystine) connected with sulfhydryl bridges. Almost all
the reduced glutathione is found within the erythrocytes; its
activity is decreased in individuals who are sensitive to the
hemolytic action of drugs like acetylphenylhydrazine (Beutler
et al. 1955; Beutler 1957). Glutathione is thought necessary
to maintain stability of erythrocyte membranes, hence it is
possible that chemicals like lead may combine with its
sulfhydryl groups and predispose the red blood cells to
hemolysis. The effects of lead on glutathione may be the cause
of erythrocyte hemolysis reported with lead toxicity (Berk
et al. 1970)
.
Iron accumulates in bone marrow cells due to the effects
of lead on the heme synthetase enzyme. PB-reaction iron
granules have been reported by Ritcher (1978) in human patients
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with lead poisoning. Other cells (leukocytes and macrophages)
can also accumulate iron granules, principally as ferritin and
hemosiderin. Iron granules are frequently seen in normoblasts
(sideroblasts) and macrophages in hemolytic anemias (Tschudi
et al. 1977) . The number of bone marrow cells with the PB-
reaction showed a decreasing trend following therapy with
CaEDTA. Ritcher (1978) reported that ferritin or hemosiderin
vanished within 4 days from human bone marrow when lead adminis-
tration was terminated. This did not occur in our dogs.
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INCIDENCE
All species are susceptible to lead poisoning, but it
is most frequent in cattle, horses, waterfowl, dogs and
children. In dogs, it is most frequent in those less than
one year of age, and this may be due to their bizzare
chewing and eating habits. ' It has been reported that
4% of hospitalized dogs under 6 months of age at Angeli
9 in 12
Memorial Animal Hospital in Boston had lead poisoning. '
Lead poisoning is seen mainly in summer and fall. This
may be due to a higher level of vitamin D which increases
intestinal absorption of lead or because dogs spend more time
outside during these seasons, where lead sources are more
readily available. ' ' ' ' Dogs in slums have higher
incidence of subclinical poisoning. These dogs may become
clinically sick when they are stressed. Lead deposits in
the body, particularly large doses, can be mobilized during
6 10
the course of canine distemper infection. '
SOURCES
The most common source of lead poisoning is lead
paint. ' ' ' Interiors of homes covered before 1940
often contain layers of lead-based paint. Exteriors of
buildings and fences are frequently covered with lead paints.
Lead chromate is one of the common constituents of paints.
Soil and vegetation may become contaminated with lead
49
from painted structures, industrial contamination or auto-
4
mobile exhaust. The concentration of lead in the soils,
exclusive of areas near lead deposits, has a range of 2 to
13200 ppm, with an approximate mean of 16 ppm. Plants can
translocate soluble lead through their roots to leaves and
fruits
.
The natural concentration of atmospheric lead has been
3
estimated at 0.0005 ug/M as compared to the average of
0.79 ug/M in urban air. The amount in fresh air has been
13
estimated at about 1 to 10 ug/L . Some pet foods may
2
contain up to 7 ppm of lead. Lead pipes can be another
readily available source of lead in water, if the water is
acidic.
Other sources of lead include linoleum, batteries,
plumbing material, putty, lead foil, solder, golf balls,
certain roofing materials, lubricants, rug pads, improperly
glazed ceramic water bowls, lead weights, fishing sinkers,
1 2drapery weights and toys. ' Newspapers and magazines used
as litter may result in doses of lead when ingested. The
lead content varies according to the ink, paper and printing
process. In one study, newspapers averaged 8 ppm per page;
black and white printed pages of magazines 10 ppm; and
colored pages of magazines 2,3400 ppm. '
ABSORPTION
Very little ingested lead is absorbed from the gastro
intestinal tract. It is probable that not more than 5 to 10
percent of ingested lead is absorbed from the gut. In
50
animals, the amount of lead absorbed from the gut appears
to be less than in man. Sheep and rabbits, for example,
take up less than 1.5% of administered lead over a range of
2-108 mg Pb/day. Zook maintains that young dogs retain
36% of their dietary lead, whereas adults retain only 10 per
cent. Several months of ingestion of diets containing 100 pom
of lead and doses as low as 0.3 mg/kg/day have been toxic to
immature dogs .
^
DISTRIBUTION
A large portion of absorbed lead is retained initially
in soft tissues as diphosphate and later in bone as
insoluble triphosphate. Following acute toxicity lead is
easily detected in soft tissues; however, deposition in the
bone requires chronic exposure to lead source. Of the
retained lead, 6 0% is located in bone; 25% in the liver;
4% in the kidney; 3% in the intestinal wall; 3% in the
reticuloendothelial system; and 5% in other organs. '
Lead intake
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Red blood cell,
bound lead
Plasma protein,
bound lead
Gastrointestinal
Respiratory
Dif fusable
plasma lead
Hard tissue lead
Dense bone, hair,
teeth
Soft tissue lead
Brain, kidney,
liver, bone marrow
Lead out
Urine, sweat
Gastrointestinal excretion
Fig. 1. Schematic view of lead metabolism.
EXCRETION
Lead is slowly removed from the body, primarily by the
kidneys. Biliary and milk excretion also occurs. In mice
more lead is apparently retained in the body and less
excreted in urine and faeces at high environmental
4,10temperatures.
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TOXICITY
The form in which lead is administered does not appear
to affect its absorption. Calves, poisoned with a series
of lead salts, showed little difference in uptake when the
lead was given as the acetate, phosphate, oxide or carbonate
or even as dried paint flakes. Table 1 shows toxicity of
various salts and the routes.
Table 1
Relative toxicity of lead and its compounds
Order of toxicitv
Method of introduction
Injection Inqestion Inhalation
Most toxic Lead arsenate
Of similar but a Metallic lead
lower degree of Lead carbonate
toxicity Lead chromate
Lead monoxide
Red lead
Lead dioxide
Lead phosphate
Lead sulphate
Lead sulphide
Lead arsenate
Lead carbonate
Lead monoxide
Lead sulphate
Metallic lead
Lead chromate
Red lead
Lead dioxide
Lead phosphate
Lead sulphide
Lead carbonate
Lead monoxide
Metallic lead
Lead arsenate
Lead chromate
Red lead
Lead dioxide
Lead phosphate
Lead silicate
Lead sulDhide
From Fairhall and Sayers (1940)
ii
(Cited bv Waldron and Stofer, 1974)
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CLINICAL SIGNS
Two kinds of clinical signs occur in dogs - gastro-
intestinal and nervous. Although either may occur separately,
most cases show both signs. Usually gastrointestinal signs
precede nervous signs. Anorexia and vomiting appear first. ' '
Colic, apparently due to smooth-muscle spasms induced by
4lead is evident by restlessness, whining, groaning and
tender abdomen. Constipation has been recorded. Gastro-
2intestinal signs have been seen in about 90% of the cases.
The severity of nervous signs increase as exposure to
lead continues. Initial signs may be observed as twitching
during sleep. Later periodic convulsions and fits are quite
common with continued exposure, and epilepsy is often
diagnosed. Hysteria is a consistent manifestation.
290-95% of dogs with hysteria have lead poisoning. Other
signs of brain or nerve injury include: nervousness, whining,
behavioral changes, retraction of the eyeball with protrusion
of the nictating membrane, photophobia, miosis, incoordination,
2 4paresis, stupor, esophageal paralysis and apparent blindness. '
Fever, respiratory embarrassment and conjunctivitis,
although occasionally reported, may be due to concommitant
1 4disease. ' Dogs exposed to chronic lead intoxication show
a marked weight loss, and this may be due to malabsorption of
nutrients from gastrointestinal tract, the latter being
inflamed.
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Differential diagnosis based on history and clinical
signs includes heavy metal poisoning, intestinal parasitism,
intussusception, canine hepatitis, acute pancreatitis, heat
stroke, encephalitis, rabies and most commonly, canine
., . 1,2,10distemper.
MECHANISM OF ACTION
Lead causes anorexia, colic, loss of weight by its
severe astringent action on the mucosa of gastrointestinal
tract, leading to gastroenteritis; hence subsequent mal-
14
absorption of nutrients and gradual emaciation. Bellies
suggests that weakness of extensor muscles, as well as the
gastrointestinal signs, may be related to peripheral neuro-
pathy and not to a direct effect on the intestinal mucosa.
Seizures are as a result of direct toxic effect on the
motor neurons of the brain.
Anemia is as a result of hemolysis of circulating
erythrocytes and defective hemoglobin synthesis in the bone
marrow. At least three enzymes involved in hemoglobin
synthesis are inhibited by lead. Lead affects these
enzymes by combining with their sulfhydril (-SH) groups.
CLINICAL DIAGNOSIS
Like any other poisoning, a diagnosis of lead intoxi-
cation is dependent on anamnesis of lead exposure to the
animal. History of the owner having seen the animal licking
painted walls or chewing batteries should be helpful.
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Clinical signs described above should form a tentative
diagnosis, pending laboratory diagnosis.
Hematologic findings in dogs with lead poisonings are so
consistent that they are almost pathognomic. Typical blood
changes precede clinical signs except in rare, acute
poisonings. Because lead interferes with hemoglobin synthesis,
the rubricyte nucleus is retained in the bone marrow for
a long time, resulting in variable number of nucleated red
blood cells (metarubricytes) in peripheral blood. Basophilic
stippling of erythrocytes is almost a constant feature of the
disease. Stippled red blood cells (rbc's) contain clusters
of very fine blue dots or large blue-black granules, best
seen in unfixed direct smears stained with neutral Wright-
2
Giemsa stain. Prolonged exposure to anticoagulants -
ethylene-disodium diamine tetraacetic acid (EDTA) may decrease
the number of stippled cells by 25 to 30%. The stippling
effect occurs when the blood film is prepared and consists
7
of clumped ribcsomes. Stippled rbc's are altered immature
rbc's which would be reticulocytes if stained supravitally.
Basophilic stippling may be seen in some dogs with marked
and prolonged anaemia, but rarely to the same degree as in
3lead poisoning. Although stippling is good evidence for
lead poisoning, a diagnosis of lead poisoning cannot be
ruled out when stippling does not appear. Other associated
findings are absolute neutrophilia with a left shift,
4
eosinopenia and monopenia.
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Q
Blcod lead analysis is the best single antemortem test
to confirm lead toxicity, although blood levels and the
4
severity of signs are not related. Assessment of lead in
hair or urine is seldom of diagnostic value. Analysis of lead
gin liver is the most reliable test to diagnose lead poisoning.
The concentration of blood lead level in normal dogs ranges from
0.1 to 0.5 ppm. Levels above 0.6 ppm are diagnostic of lead
poisoning, but poisoning may be associated with levels in the
upper normal range , especially with sporadic or past absorp-
7ticn of lead. Normal lead concentration in liver ranges up
to 3.5 ppm on a wet weight basis. Values of 5 to 10 ppm are
suspicious of lead poisoning and greater than 10 ppm consti-
2
tutes a definite diagnosis. Lead levels in the kidney greater
7
than 10 ppm are considered diagnostic.
Radiopaque ingested lead substances may be visible in
radiographs but must be distinguished from gravel or bone
2 4
chips. ' Lead lines may be visible in the metaphyses of
long bones, particularly radius, ulna and metacorpals. These
metaphyseal scleroses develop in immature dogs poisoned
over 10 days and appear as dense white bands approximately
2 4 9 10
2 to 4 mm thick just proximal to the epiphyseal plate. ' ' '
More active growth plates show more pronounced effects of
lead poisoning. Lead deposited during endochondral ossifi-
9
cation adds little or nothing to the radiopacity. The
change is the result of incorporation of lead into sites of
active bone formation which results in a dense zone of
2
mineralized cartilage and bone.
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PATHOLOGY
Gross changes at autopsy are generally non-specific.
Particles of lead paint or other lead substances may be found
in the gastrointestinal tract. Gray-black staining of
mucosa of the large intestine may result from precipitation
of lead sulfide. Longitudinally split long bones may contain
white bands at the metaphysis, although radiographs may
disclose these sclerotic areas even when they are grossly
t 2,10inapparent.
Histologic changes may help in diagnosis. Chromatin
marginates and nuclei enlarge, followed by appearance of
eosinophilic, acid-fast, intranuclear inclusion bodies in
renal and hepatic epithelium. Histologically, sclerotic
metaphyseal areas consist of increased numbers and thickness
of metaphyseal trabeculae containing calcified (and leadified)
cartilagenous cores, which result from the inability of
osteoclasts to resorb altred cartilage. Osteoclasts hyper-
trophy and proliferate. Unaffected osteoblasts continue to
lay down new bone on the persisting trabeculae. Vitamin D,
phosphorus or bismuth intoxication may be confused radio-
graphically and grossly with these lesions. Lead replaces
calcium in the apatite crystal and supposedly responds to
parathomone.
Lead encephalopathy is characterized by vascular damage,
hemorrhages, edema and areas of neuronal necrosis. In
dogs cerebrospinal fluid pressure is usually normal and the
brain is not swollen grossly. Other lesions include excess
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hemosiderosis and erythrophagocytosis , bone marrow hyper-
plasia and extramedullary hematopoiesis
,
pancreatitis and
pancreatic fibrosis, necrosis of striated muscle fibers, and
2 indecreased fertility or sterility. '
TREATMENT
Therapy of lead poisoning is designed to prevent further
absorption by removing lead from gastrointestinal tract,
the blood, and body tissues rapidly and to alleviate marked
neurological signs. Lead should be removed from intestinal
tract before chelation therapy, as chelating agents may
4
enhance absorption of lead. Gastrointestinal tract should
be cleaned by the use of enemas, laxatives, emetics or
7
surgery may be required.
Chelating agents remove lead from the body by forming
2
non-toxic compounds that are readily removed by the kidney.
Currently the chelating agent of choice is calcium disodium
ethylenediaminetetracetate (CaEDTA) usually administered at
12the rate of 10 mg/lb four times daily for 4 to 5 days.
Daily dose should not exceed 1 g nor should therapy be
continued for more than 5 consecutive days. Side effects of
CaEDTA have been reported in dogs and these include:
depression, anorexia, vomiting and diarrhea. The drug
depresses turnover of DNA and effects normal regrowth of
2
epithelial cells of intestinal vili. The mam action of CaEDTA
is to remove lead from bony tissues, not from soft tissues.
Too rapid mobilization can cause signs of acute lead
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poisoning. CaEDTA is generally administered IV in 5%
dextrose or SQ at a concentration of no more than 10 mg
CaEDTA per ml solution. Significant improvement usually
occurs in 36 to 48 hours.
Barbiturates or tranquilizers may be used to control
convulsions. Mannitol or dexatmethazone may be used to
relieve cerebral edema. Supportive therapy should be pro-
2
vided as required. Prognosis is generally good and depends
on the promptness of treatment and degree of neurological
involvement. If therapy is initiated immediately, recovery
is rapid in 95% of the cases involved. '
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A LITERATURE REVIEW OF EFFECT OF LEAD IN BONE MARROW
63
HEMATOPOIESIS
After birth, erythropoiesis
,
granulopoiesis, and mega-
karypoiesis occur principally in the bone marrow. At first,
the marrow of all bones is active in blood-cell production
since there is more demand for replacement of fetal erythro-
cytes with red blood cells more suited to serve the air-
breathing mammal. As demand for erythrocytes decreases with
approaching maturity, hematopoiesis recedes from the shafts
of long bones. ~ Red, hematopoietically active marrow is
replaced by resting yellow marrow. Active hematopoiesis
continues throughout life in all flat bones, such as the
sternum, ribs, pelvis, vertebrae, and skull, as well as
13 8the epiphyses of long bones. ' ' Hematopoiesis takes place
in the space between the vascular sinuses of the bone
1
marrow.
The yellow marrow is limited to three types of cells:
reticular cells, which are connected with the endosteum and
blood capillaries; the endothelium forming the walls of
capillaries and sinusoids; and the fat cells. The fat
cells act to occupy space as hematopoiesis recedes and to
give up space as demand for expansion of red marrow occurs
in response to continuous blood loss or hemolytic anemia.
Transition of yellow to red marrow is influenced by the
hormone erythropoietin.
Blood supply of the marrow consists of the arterial
system that runs longitudinally through the axis of the bone
64
and gives off radial branches that terminate at the periphery
of the marrow to form vascular sinuses that carry the blood
back to central vein. The sinusoidal microcirculation is
designed specifically to serve hematopoiesis , and when it is
irreversibly injured, as demonstrated in locally irradiated
2bone marrow of the rat , hematopoietic regeneration initially
took place 2 to 6 months later. Aplasia developed as the
sinusoidal microcirculation became disrupted by chronic
changes in bone marrow structure.
THE STEM CELL
To continue production of blood cells, it is postulated
that a compartment of primitive stem cell exists in the
bone marrow that initiates production of additional precursor
cells for the specific cell line that requires expansion.
The origin of erythrocytes and all leucocyte types from
a pluripotential stem cell has gained acceptance as the
most logical explanation of events in cell replacement
following experimental destruction of hematopoietic cells by
4 5 6irradiation. ' ' The demonstration of Philadelphia
chromosome designated (Ph^) by Whang in erythroid, granulo-
cytic and possibly megakaryocytic cells of leukemic patients
further implicates a common precursor cell for each of the
three cell lines. The stem cell is considered a primitive
cell of mesenchymal origin existing in the bone marrow and
other hemopoietic tissues. Its presence has been demonstrated
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in circulating blood. y ' 10 /H Lewis observed the stem
cell content of bone marrow cells to be 50 to 150 times that
13
of normal blood leucocytes in mice, and Loutit postulated
a stem cell concentration of 1:1,000 cells in bone marrow
and 1:100,000 leucocytes in blood. It is not known how the
stem cell gets into bone marrow; erythropoietin has been
14incriminated. Fliedner administered radiolabeled triated
thymidine (-^HTdR) to pregnant rats every 6 hours from the
ninth day of pregnancy to paturition. Autoradiographs
indicated that all cells of newborn rats were heavily
labelled. A significant number of cells which were neither
leucocytic nor erythrocytic in origin were also labelled
3for weeks. He further administered some additional HTdR to
newborn rats every 8 hours for 6 weeks. He treated one
group with hydroxyurea to produce hypoplasia of the bone
marrow. These rats were sacrificed at intervals, a rapid
recovery of hematopoiesis followed in 2 to 3 days after the
last dose of hydroxyurea, with full recovery within two
weeks. The label appeared in marrow lymphocytes, blast
cells, and early precursors of hematopoietic cells. These
studies apparently support the hypothesis that the stem
cell is a small lymphocytelike cell that on demand can give
rise to granulocytic, megakaryocyte and erythrocytic pre-
cursor cells.
It is thought that the primitive stem cell becomes a
'committed hematopoietic precursor cell' and this may be under
the influence of erythropoietin hormone which is produced in
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the kidney glomerular epithelium. Anoxia is thought to be
the stimulus of erythropoiesis. Committed stem cell differ-
entiates into recognizable hematopoietic cells by specific
IP 17poietins of which erythropoietin is the best known. '
Thus, different cell series become differentiated like
rubriblasts leading to increased erythrocytes, myeloblasts
leading to increased leucocytes, and megakaryoblasts leading
to increased megakaryocytes. There are two models of stem
cells :multipotential stem cells are capable of differen-
tiating into the various cell series of the bone marrow;
unipotential stem cell theory proclaims individual stem cells
for the various cells of the hemopoietic system. Multi-
potential stem cell is the most accepted way by which blood
11 • * 7 ' 14cells originate.
BONE MARROW CELLS
Ervthrcid Series.
Rubriblast . This is a round large cell presenting a
narrow rim of dark blue cytoplasm. The nucleus occupies
most of the cell, is usually centrally located but may be
eccentric. The chromatin is finely stippled and of a
reddish tinge. Nucleoli and nucleolar rings are present.
Prorubricyte . Similar in appearance to the rubriblast,
with the exception that the nuclear chromatin material may be
less condensed, and nucleoli or rings are absent.
Rubricyte. This cell is smaller than the prorubricyte,
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and still retains a narrow rim of deep blue cytoplasm. The
nuclear chromatin is condensed and separated by light streaks
giving the so-called cartwheel appearance. In late stage
synthesis of hemoglobin is well under way and this produces
a change in the color of cytoplasm to light blue or gray.
Condensation of nuclear material progresses fast so that the
appearance is one of dark blobs separated by light streaks.
In the cat and horse normochromic rubricyte nucleus remains
viable, while the cytoplasm stains similarly to the mature
erythrocyte.
Metarubricyte . The stage is depicted by the presence of
a nonviable nucleus. The nucleus is solidly black or pyknotic.
It may be fragmented, partially extruded, or partially autolyzed
The cytoplasm may be polychromatic or normochromatic, depending
on the extent of hemoglobin synthesis.
Reticulocyte . This is non-nucleated erythrocyte that,
when stained with new methylene blue, presents one or more
granules or a diffuse network of fibrils. With Romanowsky
stains, the reticulocyte is commonly polychromatophilic and
infrequently may contain an eccentrically placed nuclear
remnant called Howell-Jolly body.
Erythrocyte . Non-nucleated definitive cell of the series
with no mitochondrial material left.
Myeloid Series
Myeloblast
.
This is a large, round to irregular cell in
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shape, with finely stippled chromatin containing one or more
nucleoli or nucleolar rings. The cytoplasm is blue (baso-
philic) but generally lighter in color than that of the
rubriblast. There are no specific granules in the cytoplasm.
Progranulocyte (Promyelocyte) . Same size as myeloblast,
and its nuclear chromatin is finely stippled. The cytoplasm
is basophilic and commonly presents reddish azurophilic granules
or primary granules. There are no specific granules.
Myelocyte, neutrophilic . This is smaller than the pro-
granulocyte, with beginning condensation of the nuclear
chromatin. The cytoplasm is light blue and contains few to
numerous neutrophilic granules.
Myelocyte, eosinophilic . This is generally larger than
the neutrophilic myelocyte. The cytoplasm is more basic,
and the granules are distinctly orange.
Myelocyte, basophilic . This is a very rare cell in the
bone marrow preparations. In the cat, the granules are of
two types: numerous small, round, and pinkish and fewer
large, round and black. In other animals, the granules are
metachromatic or black.
Metamyelocyte (neutrophilic, eosinophilic and basophilic) .
The nucleus is indented to assume a kidney-bean shape. This
cell is no longer capable of division. The cytoplasm nay
retain a slight basophilia in the neutrophil but the other
two forms retain a bluish cytoplasm as a characteristic of
the mature cell of the series. The specific granules identify
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the cell as neutrophilic, eosinophilic, or basophilic.
Band form . The nucleus has parallel sides but twists to
conform to the space within the cytoplasm. The shape of the
nucleus is commonly seen as horseshoe or S-form. The nuclear
membrane is smooth and any irregularity of the membrane or
indentation indicates maturity has been attained, hence
requiring classification as a segmented and not a band cell.
Segmented neutrophil (Polymorphonuclear leucocyte)
. The
nucleus usually has several lobes separated by filaments,
however, monolobed nucleus is also seen. In some species this
cell is called a heterophil.
Eosinophil . The cytoplasm contains eosinophilic granules
Granules vary in size, shape, and number within the species of
the animal. The granules are eosinophilic but vary in inten-
sity of reddish color between species. The cytoplasm is
usually light blue.
Basophil . The cytoplasm is basophilic with few to many
metachromatic granules, depending on the species. Granules
are round and pinkish in the cat, although seme mature baso-
phils may retain a few small darker-staining granules.
Maturation of the Megakaryocyte
Megakaryoblast . The first recognizable cell of this
series is larger than other blast cells of bone marrow. It
has two reddish nuclei with a distinct chromatin pattern. The
cytoplasm is small in amount and takes a deep blue stain.
Pronegakaryocyte . Maturation leads to multiplication
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of nuclei by mitotic division without division of the cytoplasm
(endocytosis) . Number of nuclei may be 4, 8, 16 or 32. In
the larger cells, the nuclei are commonly fused into a single
irregular mass. The cytoplasm retains the deep blue color of
the blast form and is limited to a relatively narrow rim around
the nuclear mass.
Megakaryocyte . The cytoplasm is pale and presents pinkish
azurophilic granules. The cytoplasm is increased considerably
over that of the promegakaryocyte. The formation of granules
begins in the perinuclear zone and gradually extends to the
periphery of the cell. Cell size is variable and depends
upon the number of nuclear divisions that had taken place before
DNA synthesis was terminated by the beginning maturation of the
cytoplasm. In films of aspirated bone marrow, some megakaryo-
cytes may present pseudopodlike extensions and a nuclear mass
without cytoplasm, or cytoplasm without a nucleus may be
encountered.
Thrombocytes or platelets . Individual platelets are
cytoplasmic structures of megakaryocytes. They vary in shape
and in size and contain reddish granules in a light blue field.
In blood, they are often commonly clumped.
Other Cells
There are other cells usually not classified. These
include osteoclasts, mitotic figures, hematogones which are
round, pyknotic nuclei extruded from metarubricytes , lympho-
cytes especially small type, monocytes, macrophages, plasma
cells, reticuloendothelial (RE) nuclei which are
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pinkish-staining roundish structures containing one or more
blue nucleoli, unclassified cells, and degenerated cells.
EFFECTS OF LEAD ON CIRCULATING RED CELLS
Osmotic Fragility
A great deal of the work on the pathogenesis of the anemia
* , * u u -i^k u 1,18,19,20of lead poisoning has been carried out by many workers.
13
These authors found that normal washed red cells became more
resistant to hypotomic saline after exposure to lead chloride
solution. Cells that had been exposed to solutions of lead
of concentrations as high as one part per 100,000 did not
hemolyse in 0.1% saline whereas normal cells were completely
hemolysed in 0.25% saline. These observations on the effects
of lead on the osmotic fragility of the red cell have been
almost unanimously corroborated. Indeed the only dissenting
voice seems to be that of Scroczyriski (cited by Waldron) who
induced chronic and acute lead poisoning in rabbits by injecting
a 0.9% solution of alkaline lead acetate into the marginal vein
of the ear and found that red cells from both groups of animals
shewed a marked decrease in resistance to hypotonic saline
solutions. The resistance was markedly decreased in the acute
group than in the chronic group. Many authors, however, have
recorded a normal or increased resistance to hypotonic saline
solutions
.
The mechanism by which lead causes osmotic changes in
red cells is not as yet understood. Lead affects the cation
permeability of the cell membrane resulting in increased
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potassium (K ) loss. At concentrations of 100 uM/L, potassium
loss is much increased, the effect decreasing with time. It
is thought that increased osmotic resistance may indicate that
more water could enter the cells before a critical spheroidal
form is reached and lysis occurs. No recent literature has
been reported on osmotic fragility.
Mechanical Fragility
Although Aub et al. (cited by Waldron ) found that the
osmotic fragility of the red cells exposed to lead decreased,
they found, by contrast, that the mechanical fragility was
much increased. From his observations, Aub et al. concluded
that red cells exposed to lead were less able to withstand
the dynamic trauma consequent upon passage through the
capillaries and so broke up more readily than normal cells,
giving rise to the anaemia of lead poisoning. An increase
in mechanical fragility was reported in cases of human
1 8plumbism. It was found that mechanical fragility index of
1
8
red cells was markedly increased on standing , and the
disparity between their results and those of the earlier
workers would be explained if the blood used by older workers
was not fresh, i.e. had stood for more than one hour. In four
of the 10 cases reported, incubation caused a more than
18
normal increase in mechanical fragility (16.5%, 19.7%,
22.2%, and 26% compared with a mean control of 10.5 + 3.5%).
The mechanism by which lead causes an increased
mechanical fragility is not well understood. It has been
i o 20
reported that lead decreases half life time of erythrocytes ' ,
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and this may document for hemolysis from increased mechanical
fragility. No recent literature has been reported on this
subject. Mitema^ and Oehme (submitted data) have recently
investigated if lead has any effect on glutathione activity.
They observed no significant changes in activity of the
enzyme in lead dosed animals compared to control animals.
Gluthathione is a tripeptide, with sulfhydryl (-SH) group
compound, which is thought to protect red blood cell
membrane and integrity.
Red Cell Survival
Relatively few studies on the red cell survival time in
experimental or human lead poisoning have been made. The
most comprehensive study has reported, significantly lower
values than normal were obtained using both radio-chromium
1 o
tagging. It has been reported that cells removed from
two of four patients with lead poisoning had a significantly
shorter half-life (T*j) , 20 days than the normal, 27 to 34
1 8days . After treatment with ethylene diaminetetra acetic
19
acid (EDTA) the Th returned to normal. Leikin and Eng
reported erythrocyte survival times in seven children with
lead poisoning. The T% was reduced in five of the seven
patients, the shortest survival times being seen in those
children with the shortest exposure to lead. Although there
seems no doubt that in some cases of lead poisoning, a
shortened red cell life span is found. It is reported that
anemia may not result until the life span is less than 40
days. Above this value compensatory erythropoiesis is
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sufficient to prevent anemia developing. The mechanism by
which lead produces a shortened life span in red cells is not
clear, but it seems likely to be an effect on the developing
red cells in the bone marrow, where the concentration of lead
is higher than in the peripheral blood.
Stippled Cells
These are invariable but by no means constant accora-
18 — 20 2 2 — 2 4paniment of lead poisoning. *«/" ^** -phe enumeration of
the number of stippled cells in the peripheral blood has
been advocated as a means of controlling exposure to lead,
but nowadays, stippling is generally regarded as an unreliable
index of lead absorption. The degree of stippling does not
correlate well with the intensity of exposure and is found in
a wide variety of other hematological disorders, like
hemolytic anaemias, thalassaemia, leukemia, and after exposure
to aniline, arsenic, benzene, carbon monoxide and copper.
Stippled cells origin is not well understood, however, they
are thought to be degenerative or regenerative changes
18 22
occurring in the ribosomes ' of red blood cells. These
cells can be seen both in peripheral blood smears and bone
marrow preparation smears. Another study concluded that the
stipple material is composed exclusively of ribonucleo-
1
8
proteins. Electron microscopic studies showed that the
stipple material might be aggregates of ribonucleic acid
18(RNA) around the mitochondria.
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HEMOGLOBIN SYNTHESIS
The mechanism of porphyrin synthesis is now well-known
and a number of comprehensive surveys have been devoted to
this study. 23 ' 25 " 29 Studies with 15N- and 14C-labeled
23glycine have shown that glycine provides the nitrogen atoms
and eight carbon atoms, whilst succinyl CoA supplies the
remaining 26 carbon atoms for synthesis of protoporphyrin
molecule. 'Activated' glycine and 'activated' succinic acid
(succinyl CoA) react to form delta-amino-levulinic acid (ALA)
.
The delta-ALA is synthesized only in mitochondria of red
blood cells, and ALA synthetase is the rate-limiting enzyme
in the entire sequence. Pyridoxal phosphate (vitamin B ) is
6
necessary for the activation of glycine required for its
initial condensation with succinyl CoA; an abnormality in
the metabolism of this enzyme results in hypochronic anaemia
correctable only with Vitamin B^. Pantothenic acid is a2 6
component of coenzyme A, hence it is required for the
formation of delta-ALA. Its deficiency is known to produce
hypochromic anaemia in birds and animals, but not in man.
Two molecules of delta-ALA react to form a substituted pyrrole,
porphobilinogen (PBG) . Four molecules of PEG react, ultimately
forming the tetrapyrrolic ring component, uroporphyrinogen III.
Both uroporphyrinogen I synthetase and uroporphyrinogen co-
synthetase are required for the formation of uroporphyrinogen
III. Uroporphyrinogen III is converted to coproporphyrinogen
III and then to protoporphyrinogen, which, upon oxidation,
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yields protoporphyrin III. Protoporphyrin III subsequently
combines with four moles of iron to form heme, four molecules
of which finally conjugate with four globin molecules to form
hemoglobin molecule.
EFFECT OF LEAD ON HEME SYNTHESIS
The effect of lead on heme synthesis is shewn in Fig. 1.
At least three steps in heme synthesis may be affected by
lead. Delta-ALA dehydratase (ALA-D) is probably the enzyme
in the heme pathway that is most sensitive to lead.
Inhibition of this enzyme results in a block in utilization
of delta-ALA and in subsequent decline in heme synthesis.
31Granick and Levere have proposed a negative feedback
control of heme synthesis in which delta-ALA synthetase
activity is repressed, resulting in increased activity of
the enzyme and increased synthesis of delta-ALA. Hence rise
of delta-ALA in urine and blood. A third abnormality of
heme synthesis in lead intoxication is inhibition of the
32
enzyme ferrocheletase (heme synthetase) . Ferrochelatase
catalyzes the incorporation of the ferrous ion into the
porphyrin ring structure. Hence inhibition of the enzyme
may lead to accumulation of iron in the form of apoferitin
and ferruginous micelles in mitochondria of bone marrow
22
reticulocytes of lead poisoned animals.
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STAINABLE IRON GRANULES IN LEAD POISONING
In cases of chronic lead poisoning it has been seen
that Prussian blue (PB) reaction is seen in the early
erythroid series and macrophages in the bone marrow. 3 ~ 35
Developing erythroid cells which contain stainable iron
granules are known as ' sideroblasts ' . These cells are found
normally, but they are absent, or their number is greatly
reduced in patients with iron deficiency anemia. Iron
granules are usually seen in hemolytic anemias in the form
of ferritin or hemosiderin.
Ferritin is a complex macromolecule with protein subunits
that form around an inorganic core of iron oxyhydroxide
abbreviated as (Fe 00H) . The core also contains phosphate
A
up to one-eighth its own mass. In fully loaded molecule of
ferritin, core iron constitutes approximately 26% of the dry
molecule mass. Hence, a single molecule of ferritin may
contain 400 atoms of iron. 33 By contrast, natural apoferritin
(the protein moeity) contains only traces of iron. Ferritin
has a diameter of 120°A and is isometric. It can be synthesized
by many cells - hepatocytes , erythroblasts , fibroblasts,
columnar absorbing cells and heart muscle cells.
Hemosiderin has been used to denote iron-positive granules
which after application of Potassium ferrocyanide (K.Fe(CN) )
and hydrochloric acid gives Prussian (Berlin) blue reaction
(hereafter referred to as PB reaction) . It is clear that
PB-positive material, denoted by the term "hemosiderin",
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includes both water-insoluble material that is currently
33termed "hemosiderin" by biochemists as well as ferritin.
Hemosiderin is chemically heterogenous, the common feature
present being hydrous ferric oxide or oxides, which are brown
and give PB-reaction. Structure of hemosiderin is not well
understood by electron microscopists.
Nearly fifty times as much lead is found in bone marrow
18
as peripheral blood ; it is therefore logical that lead
32
affects "ferro-chelatase" enzyme which catalyzes incorpor-
ation of iron into purphyrin ring during hemoglobin synthesis.
Hence inhibition of this enzyme may lead to accumulation of
iron in the form of ferritin and hemosiderin which give PB-
33
reaction. Ritcher has reported that ferritin or hemosiderin
vanishes within 4 days if no additional lead is given.
SUMMARY OF EFFECTS OF LEAD ON BONE MARROW CELLS
It is reported that lead may cause erythroid hypoplasia
in the marrow. Lead interferes with at least three enzymes
in mitochondria and cytoplasm of erythroid cells involved in
hemoglobin synthesis in bone marrow. Positive PB-reaction
due to iron granules has been seen in marrow smears of lead
poisoned patients.
No literature has reported any direct effect of lead on
myeloid or erythroid cells of the canine bone marrow. In cur
study we observed increases of the myeloid: erythroid (M:E)
ratios, segmented neutrophils, myeloid series cells, and iron
80
granules in a chronic exposure of lead (5 mg Pb Kg/b wt)
on dogs.
Lead may affect early erythroid cells by interfering
with the enzymes involved in hemoglobin synthesis, thus
arresting maturation of the cells and leading to erythropathy.
It has been reported that lead causes a shortened life span
of erythrocytes; it is possible that some of the early forms
of erythroid series may be affected as well. This may document
for erythroid hypoplasia. It is possible that lead may also
arrest the release of segmented neutrophils from the marrow
explaining for their increased number in the marrows.
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DOG No. 39
(Group 1 = Control)
Day BWT
5.0
14 7.0
28 9.0
42 11.0
56 13.0
70 16.0
84 17.5
98 19.0
112 21.0
126 —
—
No. of marrow cells
with iron granules
o
+
o
o
o
o
o
+
o
+
Day = Day of experiment.
BVJT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
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DOG No. 42
(Group 1 = Control!
Day BWT
10.0
14 14.0
28 17.5
42 20.5
56 23.0
70 26.0
84 28.0
98 30.0
112 31.0
126 —
No. of marrow cells
with iron granules
o
+
o
o
+
+
o
o
o
+
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
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DOG No. 2 9
(Group 2)
*
Day BWT No. of marrow cells
with iron granules
9.0
14 11.5
28 14.0
42 16.0
56 18.0
70 20.0
84 21.0
98 22.0
112 24.0
126 —
o
o
+
+
o
++
+++
+
++
++
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
*Group 2 = 2 mg Pb/kg
.
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DOG No. 4 3
(Group 2)*
Dav BWT No. of marrow cells
with iron granules
7.0
14 9.0
28 10.0
42 13.0
56 14.0
70 16.0
84 17.0
98 18.0
112 19.0
126 __
o
o
+
+
o
++
++
++
+
++
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
*Group 2 = 2 mg Pb/kg.
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DOG No. 3
(Group 2)
*
Day BWT No. of marrow cells
with iron granules
7.0
14 9.0
28 11.0
42 13.0
56 14.5
70 16.0
84 17.0
98 18.0
112 19.0
126 __
o
+
o
o
o
o
++
+++
+
o
Day = Day of experiment.
BWT = Body weight in lbs
.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
:Group 2 = 2 mg Pb/kg
.
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DOG No. 4
(Group 2)*
Day BWT No. of marrow cells
with iron granules
7.0
14 8.0
28 10.5
42 13.0
56 14.0
70 13.0
84 19.0
98 21.0
112 21.0
126 —
o
o
o
o
+
+
o
++
++
+
Day = Day of experiment
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
rGroup 2 = 2 mg Pb/kg.
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DOG No. 31
(Group 3)*
Day BWT No. of marrow cells
with iron granules
10.0
14 11.0
28 13.0
42 15.0
56 15.0
70 17.0
84 19.0
98 19.0
112 21.0
126 —
o
o
o
o
o
++
+
++++
++
++
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number o:
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
*Group 3 = 5 mg Pb/kg.
102
DOG No. 37
(Group 3)
*
Day BWT No. of marrow cells
with iron granules
7.0
14 10.5
28 12.5
42 12.5
56 9.5
70 14.5
84 18.0
98 21.0
112 23.0
126 __
o
o
o
o
++
o
+
o
+
+
Day = Day of experiment.
BWT = Body weight in lbs
.
No. of marrow cells with iron granules = Number o:
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
*Group 3 = 5 mg Pb/kg
.
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DOG No. 2 8
(Group 3)
*
Day BWT No. of marrow cells
with iron granules
9.5
14 12.5
28 15.0
42 16.5
56 17.5
70 19.5
84 20.5
98 21.0
112 22.0
126 —
o
o
o
+
o
+++
++
++++
+++
++
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
'Group 3 = 5 mg Pb/kg
104
DOG Mo. 3 8
(Group 3)*
Day BWT No. of marrow cells
with iron granules
7.0
14 10.0
28 12.5
42 14.0
56 14.5
70 17.0
84 19.0
98 20.0
112 23.0
126 —
—
o
o
o
+
++
+
o
+++
++
++
Day = Day of experiment.
BWT = Body weight in lbs.
No. of marrow cells with iron granules = Number of
cells with iron granules on staining with
ferrocyanide and hydrochloric acid.
*Group 3 = 5 mg Pb/kg.
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EXAMPLES OF BONE MARROW CELLS FROM EXPERIMENTAL ANIMALS
106
m f
FIG. 2. Bone marrow smear on day 70 from one
dog receiving 5 mg lead/kg daily. The cell lettered A
is a myeloblast and an unlettered cell is a lymphocyte.
FIG. 3. Bone marrow smear on day 70 from one
dog receiving 2 mg lead/kg/daily. The cell lettered B
is a band neutrophil.
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FIG. 4. Bone marrow smear on day 112 from one
control dog. The cell lettered C is a hyoersegmented
neutrophil.
*
•
D#
FIG. 5. Bone marrow smear on day 42 from ont
dog receiving 5 mg lead/kg/daily. The cell lettered D
is an eosinophil.
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FIG. 6. Marrow smear on day 98 from one dog
receiving 2 mg lead/kg/daily. The cell lettered E
is a rubriblast and the cell at the corner is a
lymphocyte.
FIG. 7. Marrow smear on day 28 from one dog
receiving 5 mg lead/kg/daily. The cell lettered F
is a rubricyte and the unlettered cell at the top
is a metarubricyte.
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G
}\
FIG. 8. Marrow smear on day 14 from one control
dog. The cell lettered G is rubricyte in mitosis
FIG. 9. Marrow smear on day 91 from one dog
receiving 5 mg lead/kg. The lettered cell is a
metarubricyte. The other unlettered cells include
rubricyte, an eosinophil and a metarubricyte.
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The undesirable environmental effects of lead have been
recognized for many years in people and animals. A prominent
effect of repeated lead exposure is the effect on erythropoiesis
,
expressed as anemia, basophilic stripping of red cells and
increased number of nucleated red blood cells in the peripheral
circulation. The purpose of this study was to evaluate the
effect of chronic lead exposure on the hemopoietic system of
dogs and to study the correlation between blood levels and
hematologic, biochemical and bone marrow cytologic parameters.
The effects of oral lead exposure on canine hematology,
blood glutathione and bone marrow cytology were studied in 10
dogs. Two dogs served as control, four received 2 rr.g lead
(as acetate) /kg daily and four received 5 mg lead/kg daily for
13 weeks. At that time, one-half of each group was treated
with calcium ethylene-diamine tetraacetate (EDTA) . All animals
were then monitored for another four weeks. Blood lead levels,
hematology, and blood glutathione were measured weekly during
the 18 weeks of study. Bone marrow cytology and iron granules
in bone marrow cells were monitored on alternate weeks.
Clinical signs of toxicosis were observed after six weeks
in only one dog in the high dose group. The signs included
emaciation, anorexia, muscular weakness, loss of weight,
evidence of abdominal pain and depression. There was no sig-
nificant change in the blood glutathione activity of any group.
There was an increase in nucleated red blood cells in the high
lead dosed group and a trend toward depression of the packed
cell volume in the same group. Dogs receiving doses of lead
had increases in bone marrow spgmented neutrophils, had
increased myeloid :erythroid (M:E) ratios, and had increased
numbers of bone marrow cells with iron granules. Statistically,
myeloid series cells and segmented neutrophils remained elevated
in EDTA-treated animals than in these not treated with EDTA;
however, this may not be of diagnostic significance. Blood
lead levels, nucleated red blood cells and M:E ratios decreased
after cessation of lead administration, and the number of mar-
row cells with iron granules showed a decreasing trend.
This study showed that the dosages of lead used altered
bone marrow cytology, but had no effect on canine hematology
and blood glutathione except for increasing the number of
circulating nucleated red blood cells and a trend toward depres-
sion of packed cell volume.
